This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Regulatory
Sort by Latest
- Sort by Latest
- Sort by Views
Transfers of value to “influencers”: new disclosure obligation for companies in the health sector
The list of beneficiaries of transfers of value subject to compulsory disclosure in the French public...
January 21, 2020
2 min read
Access to toxicity study reports and protection of commercial interests
Gerard Hogan, Advocate General at the Court of Justice of the European Union (“CJEU”) recently...
November 22, 2019
8 min read
Dutch competition authority ACM publishes a sector report on the impact of biosimilars on competition between TNF-alfa inhibitors
The Dutch competition authority, ACM, initiated a market study in 2018 into the effect of the introduction...
October 7, 2019
5 min read
Transfer of value: amendments to the French “anti-gift” provisions by the draft Health Act
The French so-called “anti-gift” provisions strictly frame the conditions under which companies...
July 2, 2019
2 min read
Investing in the future of cannabis in the UK – lessons from the German model
The excitement around the potential for the UK cannabis market – medicinal and nutritional – to continue...
June 4, 2019
27 min read
Manufacturing and stockpiling waiver set to limit rights of holders of SPCs for medicines
On 17 April 2019, the European Parliament approved, by a large majority, an amendment of the Regulation...
May 8, 2019
2 min read
Processing health data in France: What to look out for after GDPR?
French law imposes stricter requirements than the General Data Protection Regulation (“GDPR”) regarding...
March 1, 2019
3 min read
Between pharma, agriculture and narcotics: The rise of medical Cannabis in a controversial emerging regulatory environment
Since liberalisation at the beginning of 2017, industrial and medical Cannabis have experienced a boom...
December 12, 2018
3 min read
The legal basis for Belgian biobanks enters into force
10 years after its first official publication, the legal framework on biobanks has entered into force...
December 11, 2018
3 min read
Changes afoot for Belgian manufacturers of allogeneic ATMPs
Last month, the Belgian Parliament voted in favour of a set of measures that are notably meant to clarify...
December 11, 2018
5 min read